SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001144204-13-062445
Filing Date
2013-11-15
Accepted
2013-11-15 16:18:18
Documents
1
Group Members
DAVID L. DOUGLASSDEEPIKA R. PAKIANATHANDELPHI BIOINVESTMENTS VIII, L.P.DELPHI MANAGEMENT PARTNERS VIII, L.L.C.DOUGLAS A. ROEDERJAMES J. BOCHNOWSKI

Document Format Files

Seq Description Document Type Size
1 SC 13D v360531_sc13d.htm SC 13D 121475
  Complete submission text file 0001144204-13-062445.txt   123181
Mailing Address 3000 SAND HILL ROAD BUILDING 1, SUITE 135 MENLO PARK CA 94025
Business Address 3000 SAND HILL ROAD BUILDING 1, SUITE 135 MENLO PARK CA 94025 650-854-9657
DELPHI VENTURES VIII LP (Filed by) CIK: 0001436285 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13D

Mailing Address 2 MERCER ROAD NATICK MA 01760
Business Address 2 MERCER ROAD NATICK MA 01760 508-975-4820
Karyopharm Therapeutics Inc. (Subject) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-87705 | Film No.: 131224136
SIC: 2834 Pharmaceutical Preparations